212 related articles for article (PubMed ID: 2498635)
1. A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
Beitner DB; Duman RS; Nestler EJ
Mol Pharmacol; 1989 May; 35(5):559-64. PubMed ID: 2498635
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
Duman RS; Tallman JF; Nestler EJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
[TBL] [Abstract][Full Text] [Related]
3. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.
Nestler EJ; Tallman JF
Mol Pharmacol; 1988 Feb; 33(2):127-32. PubMed ID: 3340078
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
5. Regulation by chronic clonidine of adenylate cyclase and cyclic AMP-dependent protein kinase in the rat locus coeruleus.
Nestler EJ; Terwilliger R; Beitner D
Life Sci; 1989; 45(12):1073-80. PubMed ID: 2507846
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
9. The primate locus coeruleus and effects of clonidine on opiate withdrawal.
Redmond DE; Huang YH
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817
[TBL] [Abstract][Full Text] [Related]
10. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
11. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
Jones KL; Barr GA
Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
[TBL] [Abstract][Full Text] [Related]
12. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
Nestler EJ
Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
Solomon RE; Gebhart GF
J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
[TBL] [Abstract][Full Text] [Related]
14. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons.
Ruiz-Durántez E; Torrecilla M; Pineda J; Ugedo L
Br J Pharmacol; 2003 Feb; 138(3):494-500. PubMed ID: 12569074
[TBL] [Abstract][Full Text] [Related]
16. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
17. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
[TBL] [Abstract][Full Text] [Related]
18. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals.
Guitart X; Kogan JH; Berhow M; Terwilliger RZ; Aghajanian GK; Nestler EJ
Brain Res; 1993 May; 611(1):7-17. PubMed ID: 8518951
[TBL] [Abstract][Full Text] [Related]
19. In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.
Berrocoso E; Mico JA
J Pharmacol Exp Ther; 2007 Jul; 322(1):101-7. PubMed ID: 17431134
[TBL] [Abstract][Full Text] [Related]
20. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
